Zonisamide Administration Improves Fatty Acid β-Oxidation in Parkinson’s Disease

Zonisamide Administration Improves Fatty Acid β-Oxidation in Parkinson’s Disease

Although many experimental studies have shown the favorable effects of zonisamide on mitochondria using models of Parkinson’s disease (PD), the influence of zonisamide on metabolism in PD patients remains unclear. To assess metabolic status under zonisamide treatment in PD, we performed a...

Full description

Bibliographic Details
Main Authors: Shin-Ichi Ueno, Shinji Saiki, Motoki Fujimaki, Haruka Takeshige-Amano, Taku Hatano, Genko Oyama, Kei-Ichi Ishikawa, Akihiro Yamaguchi, Shuko Nojiri, Wado Akamatsu, Nobutaka Hattori
Format: Article
Language:English
Published: MDPI AG 2018-12-01
Series:Cells
Subjects:
Parkinson’s disease
fatty acid β-oxidation
long-chain acylcarnitine
Online Access:http://www.mdpi.com/2073-4409/8/1/14

Internet

http://www.mdpi.com/2073-4409/8/1/14

Similar Items